Nucleus Genomics Launches to Bring Whole-Genome Sequencing to the Public

    Nucleus Genomics, a pioneering genetic testing and analysis company, announced the debut of its DNA analysis product, marking a significant...

March 26, 2024 | Tuesday | News
New Treatment Option for Prostate Cancer Shows Successful Outcomes

    Prostate cancer treatment traditionally involves radiation or surgery, both carrying risks of adverse effects like urinary incontinence and...

March 25, 2024 | Monday | News
Within3 and Array Announce Partnership to Set New Standards in Life Science Stakeholder Engagement

    Within3 and Array have announced a strategic partnership integrating synchronous and asynchronous insights management. This partnership is ...

March 20, 2024 | Wednesday | News
Lonza Strikes Deal with Roche: Acquires Genentech Facility in Vacaville for $1.2 Billion to Bolster Biologics Manufacturing Capacity

Lonza has signed an agreement to acquire the Genentech manufacturing facility in Vacaville (US) from Roche for USD 1.2 billion in cash Vacaville (US) si...

March 20, 2024 | Wednesday | News
SCHOTT Pharma to Establish State-of-the-Art Facility in Wilson, North Carolina, Bolstering U.S. Pharmaceutical Supply Chain

   SCHOTT Pharma announces plans to solidify its footprint in the United States with the establishment of a cutting-edge facility in Wilson, Nor...

March 19, 2024 | Tuesday | News
Orchard Therapeutics Achieves Landmark FDA Approval for Lenmeldy™, Pioneering Gene Therapy for Early-onset Metachromatic Leukodystrophy

Orchard Therapeutics, now under the stewardship of Kyowa Kirin, announces a historic milestone as the U.S. Food and Drug Administration (FDA) grants approv...

March 19, 2024 | Tuesday | News
Biotech Lobbying Powerhouse BIO Ends Association with WuXi AppTec Amid Security Crackdown

Biotechnology Innovation Organization (BIO), a leading lobbying group in Washington, D.C., announced its decision to sever ties with WuXi AppTec, a Chinese...

March 15, 2024 | Friday | Reports
Kenai Therapeutics Secures $82 Million Series A Funding to Advance Parkinson's Disease Treatment Trials

  – Proceeds will be used to complete clinical demonstration trials of the lead candidate drug RNDP-001 for the treatment of Parkinson's di...

March 11, 2024 | Monday | News
Special Spotlight Report: GSK's COiMMUNITY Initiative Boosts Adult Vaccination Rates

  Rob Truckenmiller, Senior Vice President, Head of US Vaccines, GSK, emphasized the importance of collaborative efforts and fi...

March 08, 2024 | Friday | Reports
HHS Takes Decisive Action in Wake of Change Healthcare Cyberattack

  Recognizing the severity of the cyberattack, HHS has been actively engaged in regular discussions with UHG leadership, state partners, and a wide a...

March 07, 2024 | Thursday | News
Biocon Biologics Gains Rights to Launch Stelara® Biosimilar in the US by 2025 Following Janssen Settlement

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced...

March 04, 2024 | Monday | News
Exact Sciences Launches Riskguard™ Hereditary Cancer Test in the United States

The test is covered by Medicare and many commercial insurance plans for eligible patients   Exact Sciences Corp., a leading provider of cancer scree...

February 29, 2024 | Thursday | News
Ember LifeSciences Partners with USADA to Revolutionize Blood Sample Shipping for 2024 U.S. Olympic Trials

  At the heart of this innovative partnership is the Ember Cube, a symbol of cutting-edge advancement in the cold chain sector. This technology is se...

February 28, 2024 | Wednesday | News
AbbVie and OSE Immunotherapeutics Forge Partnership to Develop Breakthrough Chronic Inflammation Treatment

Global license and collaboration agreement set to advance the development of OSE-230, a monoclonal antibody aimed at resolving chronic inflammation. ...

February 28, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close